Sphingolipids in Congenital Diaphragmatic Hernia; Results from an International Multicenter Study
Open Access
- 9 May 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (5) , e0155136
Abstract
Congenital diaphragmatic hernia is a severe congenital anomaly with significant mortality and morbidity, for instance chronic lung disease. Sphingolipids have shown to be involved in lung injury, but their role in the pathophysiology of chronic lung disease has not been explored. We hypothesized that sphingolipid profiles in tracheal aspirates could play a role in predicting the mortality/ development of chronic lung disease in congenital diaphragmatic hernia patients. Furthermore, we hypothesized that sphingolipid profiles differ between ventilation modes; conventional mechanical ventilation versus high-frequency oscillation. Sphingolipid levels in tracheal aspirates were determined at days 1, 3, 7 and 14 in 72 neonates with congenital diaphragmatic hernia, born after > 34 weeks gestation at four high-volume congenital diaphragmatic hernia centers. Data were collected within a multicenter trial of initial ventilation strategy (NTR 1310). 36 patients (50.0%) died or developed chronic lung disease, 34 patients (47.2%) by stratification were initially ventilated by conventional mechanical ventilation and 38 patients (52.8%) by high-frequency oscillation. Multivariable logistic regression analysis with correction for side of the defect, liver position and observed-to-expected lung-to-head ratio, showed that none of the changes in sphingolipid levels were significantly associated with mortality /development of chronic lung disease. At day 14, long-chain ceramides 18:1 and 24:0 were significantly elevated in patients initially ventilated by conventional mechanical ventilation compared to high-frequency oscillation. We could not detect significant differences in temporal sphingolipid levels in congenital diaphragmatic hernia infants with mortality/development of chronic lung disease versus survivors without development of CLD. Elevated levels of ceramides 18:1 and 24:0 in the conventional mechanical ventilation group when compared to high-frequency oscillation could probably be explained by high peak inspiratory pressures and remodeling of the alveolar membrane.Keywords
Funding Information
- SSWO (549)
- Willem H. Kröger Foundation (549)
This publication has 30 references indexed in Scilit:
- Fenretinide Causes Emphysema, Which Is Prevented by Sphingosine 1-PhoshatePLOS ONE, 2013
- Amelioration of hyperoxia-induced lung injury using a sphingolipid-based interventionEuropean Respiratory Journal, 2012
- The role of sphingolipids in respiratory diseaseTherapeutic Advances in Respiratory Disease, 2011
- Ceramide synthases 2, 5, and 6 confer distinct roles in radiation-induced apoptosis in HeLa cellsCellular Signalling, 2010
- Surfactant Maturation Is Not Delayed in Human Fetuses with Diaphragmatic HerniaPLOS Medicine, 2007
- A house divided: Ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell deathBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006
- Surfactant replacement therapy on ECMO does not improve outcome in neonates with congenital diaphragmatic herniaJournal of Pediatric Surgery, 2004
- Is surfactant therapy beneficial in the treatment of the term newborn infant with congenital diaphragmatic hernia?The Journal of Pediatrics, 2004
- Surfactant does not improve survival rate in preterm infants with congenital diaphragmatic herniaJournal of Pediatric Surgery, 2004
- Sphingosine 1‐phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthmaThe FASEB Journal, 2001